2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis

Overview of attention for article published in Frontiers in Neuroscience, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,442 followers.

RT @marshinawi: Utility of metabolomics to diagnose GABA-transaminase deficiency & the effect of anti-seizure medications. 2-Pyrrolidinone…

29 May 2019

Reply Repost Favourite

Utility of metabolomics to diagnose GABA-transaminase deficiency & the effect of anti-seizure medications. 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency:Anti-seizure Medications Impact Accurate Diagno

29 May 2019

Reply Repost Favourite

2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis https://t.co/jyZy3847RE

08 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.